Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027

Go back to Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027
(NASDAQ: TVTX) Delayed: 55.86 -0.4 (0.71%)
Previous Close $56.26    52 Week High
Open $54.80    52 Week Low
Day High $56.39    P/E N/A 
Day Low $54.32    EPS
Volume 251,078